• Advanced Accelerator Applications Reports 24.4% Sales Growth in the Second Quarter of 2016

    31 August 2016
    Download

  • Paratek Initiates Phase 3 Study of Oral-Only Omadacycline in ABSSSI

    15 August 2016
    Download

  • Im Schweizer Biotech-Segment ist viel Feingefühl gefragt

    3 August 2016
    Download

  • ObsEva initiates Phase 1 for OBE022 in Preterm Labor

    28 July 2016
    Download

  • Cell Medica Acquires Delenex Therapeutics

    12 July 2016
    Download

  • ObsEva Receives FDA Clearance to Initiate Phase 2b Study of OBE2109 in Endometriosis

    6 July 2016
    Download

  • AnaptysBio Initiates Multiple Ascending Dose Cohorts in ANB020 Phase 1 Clinical Trial

    6 July 2016
    Download

  • Advanced Accelerator Applications Announces FDA Priority Review for Lutathera

    27 June 2016
    Download

  • Paratek Announces that Omadacycline Met All Primary and Secondary Efficacy Outcomes Designated by FDA and EMA in a Phase 3 Study in Acute Bacterial Skin Infections

    16 June 2016
    Download

  • Suche nach dem Superwirkstoff gegen Krebs

    7 May 2016
    Download

  • Eiger BioPharmaceuticals Closes Merger With Celladon Renamed Eiger and New Trading Symbol (NASD: EIGR, as of March 23) Developing a Clinical Stage Pipeline of Orphan Disease Programs

    22 March 2016
    Download

  • Skyepharma to merge with Vectura Group

    16 March 2016
    Download

  • ARMO BioSciences Raises $50 Million Series C Financing

    10 February 2016
    Download

  • Kolltan Pharmaceuticals Provides Update on Clinical Pipeline, Corporate Developments and Near-Term Milestones

    8 January 2016
    Download

  • NUVASIVE to aquire Ellipse Technologies

    6 January 2016
    Download

  • Vascular Dynamics’ MobiusHD™ System Receives CE Mark for the Treatment of Resistant Hypertension

    6 January 2016
    Download

  • Allena Pharmaceuticals Raises $53 Million in Series C Financing

    9 December 2015
    Download

  • HBM co-leads CHF 60 million Series B financing of ObsEva

    23 November 2015
    Download

  • Curetis IPO priced at EUR 10.00 per Share; raises EUR 40 million

    15 November 2015
    Download

  • Allena Pharmaceuticals Announces Presentation of Successful Phase 2 Data from ALLN-177 Program at American Society of Nephrology Kidney Week

    12 November 2015
    Download

  • Advanced Accelerator Applications S.A. Announces Pricing of Initial

    10 November 2015
    Download

  • Ophthotech Completes Patient Recruitment of the Second Phase 3 Pivotal Trial of Fovista® Anti-PDGF Therapy in Combination with Lucentis® in Wet Age-Related Macular Degeneration

    26 October 2015
    Download

  • APR Applied Pharma Research (APR) announces the European Class III CE Mark approval of Nexodyn

    16 October 2015
    Download

  • Over 2000 Patients Treated with Ellipse Technologies? MAGEC® System

    1 October 2015
    Download

  • AAA Announces Positive Results From Phase 3 Study NETTER-1 Evaluating Lutathera in Patients with Advanced Midgut Neuroendocrine Tumors

    27 September 2015
    Download
    • More news